Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 3
2006 2
2007 2
2008 2
2009 4
2010 4
2011 2
2012 2
2013 3
2014 4
2015 5
2016 5
2017 5
2018 1
2019 1
2020 4
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

47 results
Results by year
Filters applied: . Clear all
Page 1
Reduction in use of cyproterone/ethinylestradiol (Diane-35 and generics) after risk minimization measures in the Netherlands, UK and Italy.
Penning-van Beest FJA, Bezemer ID, Smits E, García Rodríguez LA, Cea Soriano L, Lapi F, Simonetti M, Asiimwe A, Herings RMC. Penning-van Beest FJA, et al. Among authors: bezemer id. Contraception. 2020 Oct;102(4):243-245. doi: 10.1016/j.contraception.2020.05.010. Epub 2020 May 26. Contraception. 2020. PMID: 32470466
Rationale and design of a European epidemiological post-authorization safety study (PASS) program: rivaroxaban use in routine clinical practice.
García-Rodríguez LA, Wallander MA, Friberg L, Ruigomez A, Schink T, Bezemer I, Herings R, Shakir S, Evans A, Davies M, Suzart-Woischnik K, Vora P, Balabanova Y, Soriano-Gabarró M, Brobert G. García-Rodríguez LA, et al. Among authors: bezemer i. Expert Opin Drug Saf. 2020 Nov;19(11):1513-1520. doi: 10.1080/14740338.2020.1798928. Epub 2020 Aug 4. Expert Opin Drug Saf. 2020. PMID: 32700977
Evaluating the Effectiveness of an Additional Risk Minimization Measure to Reduce the Risk of Prescribing Mirabegron to Patients with Severe Uncontrolled Hypertension in Four European Countries.
Heintjes EM, Bezemer ID, Prieto-Alhambra D, Smits E, Booth HP, Dedman D, He Y, Hoti F, Vehkala M, de Vogel S, Robinson NJ, Appenteng K, Penning-van Beest FJA. Heintjes EM, et al. Among authors: bezemer id. Clin Epidemiol. 2020 May 1;12:423-433. doi: 10.2147/CLEP.S242065. eCollection 2020. Clin Epidemiol. 2020. PMID: 32431551 Free PMC article.
Thrombotic risk minimization for Diane-35 and generics.
Bezemer ID, Smits E, Penning-van Beest FJA, Asiimwe A, Herings RMC. Bezemer ID, et al. Pharmacoepidemiol Drug Saf. 2017 Nov;26(11):1411-1417. doi: 10.1002/pds.4319. Epub 2017 Sep 26. Pharmacoepidemiol Drug Saf. 2017. PMID: 28952198
Use of azithromycin and risk of ventricular arrhythmia.
Trifirò G, de Ridder M, Sultana J, Oteri A, Rijnbeek P, Pecchioli S, Mazzaglia G, Bezemer I, Garbe E, Schink T, Poluzzi E, Frøslev T, Molokhia M, Diemberger I, Sturkenboom MCJM. Trifirò G, et al. Among authors: bezemer i. CMAJ. 2017 Apr 18;189(15):E560-E568. doi: 10.1503/cmaj.160355. CMAJ. 2017. PMID: 28420680 Free PMC article.
Type 2 Diabetes Treatment Patterns Across Europe.
Heintjes E, Overbeek JA, Blin P, Hall GC, Lapi F, Prieto AD, Bezemer ID. Heintjes E, et al. Among authors: bezemer id. Value Health. 2014 Nov;17(7):A359. doi: 10.1016/j.jval.2014.08.779. Epub 2014 Oct 26. Value Health. 2014. PMID: 27200724 Free article. No abstract available.
Outcomes in patients with lung cancer treated with crizotinib and erlotinib in routine clinical practice: A post-authorization safety cohort study conducted in Europe and in the United States.
Ehrenstein V, Huang K, Kahlert J, Bahmanyar S, Karlsson P, Löfling L, Nunes AP, Enger C, Bezemer ID, Kuiper JG, Hoti F, Juuti R, Korhonen P, Mo J, Schachterle SE, Wilner KD, Rørth M, Sørensen HT. Ehrenstein V, et al. Among authors: bezemer id. Pharmacoepidemiol Drug Saf. 2021 Jun;30(6):758-769. doi: 10.1002/pds.5193. Epub 2021 Jan 24. Pharmacoepidemiol Drug Saf. 2021. PMID: 33428292
47 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page